SOLUM AMINOS
COA-SA-2606-058-R1
Certificate of analysis
PT-141 10mg
Bremelanotide · Research use only
- Lot
- SA-2606-058
- HPLC
- 98.7%
- Identity
- MS confirmed
- Analysed
- 19 Jun 2026
Analytical results
| Test | Specification | Result |
|---|---|---|
| Appearance | Lyophilised cake | Lyophilised powder |
| Purity (RP-HPLC, 220 nm) | ≥98% | 98.7% |
| Identity | Conforms to sequence | MS confirmed |
| Form | Lyophilised powder | Lyophilised powder |
| Compound | As labelled | PT-141 / bremelanotide |
| Mass | As labelled | 10 mg |
| Storage | 2–8°C, dry, protected | 2–8°C, protected from light. |
| Re-test date | 24 months from analysis | 19 Jun 2028 |
RP-HPLC chromatogram
C18 · 220 nm · lot-matched trace for SA-2606-058 · re-test 19 Jun 2028
Methods
- Purity determined by reversed-phase HPLC (C18, UV 220 nm) against the current lot specification.
- Identity confirmed by electrospray ionisation mass spectrometry of the intact peptide.
- This certificate refers only to lot SA-2606-058. The unit you receive is from the same manufacturing batch.
Authorised
SOLUM AMINOS QC · Melbourne
Issued
19 Jun 2026
For laboratory research use only. Not for human or animal consumption, compounding, or therapeutic use. Not evaluated by the TGA. desk@solumaminos.com.au